Skip to main content

Soccer transfer news, rumors: Cristiano Ronaldo angling for Napoli swap, PSG medical for Fabian Ruiz and more

What’s better than a cup of coffee and the latest transfer news? Join in as CBS Sports provides the latest updates from around the world and what they mean to your favorite teams. Forwards are on the move around the world as Wolves are adding Stuttgart forward Sasa Kalajdzic to bring more competition to lead the line. Fabian Ruiz is also closing in on a move to PSG but the biggest name striker on the market, Cristiano Ronaldo’s situation remains still stagnant. The Portuguese forward wants out of Manchester United but finding a deal is easier said than done at this stage.

Let’s get to the transfer moves:

In the six-yard box

The biggest transfer stories of the day. These are the deals that are happening, or at least on the verge of getting done.

Wolves improve their forward options by adding Sasa Kalajdzic

The Stuttgart forward has been signed

Raffles Medical Group Sees China On The Mend From Covid As Its Expansion Continues

China is gradually getting back to normal after disruptions earlier this year in connection with the Covid pandemic, the local leader of Singapore’s largest private healthcare provider said at the 3rd Forbes China Healthcare Summit on Saturday.

“Covid has presented us with a lot of challenges operationally,” said Dr. Vincent Chia, managing director of Raffles China Healthcare, a subsidiary of Raffles Medical Group in Singapore. “Things are starting to look slightly more relaxed, but in a very coordinated fashion,” he said.

Raffles Medical Group has been operating in China since 2010. It provides healthcare service in eight cities, including Hong Kong. That accounts for more than half of its current total of 14 across Asia.

This year, Raffles China Healthcare

Louisiana set to expand medical marijuana business, allow for new pharmacies | Local Politics

Louisiana’s insular medical marijuana industry — which is seeing a flood of new customers and a spike in sales this year after smokable flower became legal — is set to expand further.

Earlier this month, the state Pharmacy Board notified seven of the nine legal marijuana pharmacies in Louisiana that they were eligible to open a “satellite” location. So far, the New Orleans pharmacy is the only one to submit formal plans; H&W Drug Store is seeking permission to open a storefront in Metairie.

Several other pharmacy owners are on the hunt for new locations, and say they have plans to open their satellite shops in the coming months.

And the New Orleans region will soon see yet another new pharmacy, after the Pharmacy Board goes through a bid process to pick a second licensee for the area. The Legislature and Gov. John Bel Edwards this year refused to open

Medical experts in the Ozarks warn weed vapes could send toxic gas to your lungs

BRANSON, Mo. (KY3) – A new study about weed vaping shows it could send toxic gas to your lungs.

from Portland State University found evidence of vaping cannabinoid acetates forms a deadly gas that could injure your lungs Researchers. That toxic gas, called ketene, is released when cannabinoid acetates are heated under vaping. In 2019 researchers found ketene to be dangerous and a possible source of the vaping-induced lung injury outbreak in 2020 that caused thousands of people to be hospitalized.

The study provided results based on one puff, showing ketene levels known to be dangerous to a user’s health. Researchers also mentioned that people who use these vape products likely smoke them for more than a single puff.

CoxHealth Branson Community Educator Jim Brawner explains why prolonged exposure to these products could concern users.

“As more studies come out like this one, pay attention to it,” said Brawner. “If

Chimerix Awarded BARDA Contract for TEBEXA as Medical Countermeasure for Smallpox

Chimerix, Inc.

Chimerix, Inc.

– Initial Procurement of 319,000 Treatment Courses for $115M with Additional Procurements at BARDA’s Discretion Over 10 Years –

– Emergent BioSolutions, Inc. Payment Increases to $238M Upfront and $136.5M in Potential Milestones –

DURHAM, NC, Aug. 29, 2022 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that is has signed a multi-year contract with the Biomedical Advanced Research and Development Authority (BARDA) in the US Department of Health and Human Services’ Administration for Strategic Preparedness and Response (ASPR), for the delivery of up to 1.7 million treatment courses of tablet and suspension formulations of TEBEXA® to the US government. The contract 75A50122C00047, includes an initial product procurement of 319,000 treatment courses for approximately $115 million. The 10-year contract, which contains options for future procurements, is